MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma.

Jie XuJing-Lan LiuL Jeffrey MedeirosWenting HuangJoseph D KhouryTimothy J McDonnellGuillin TangEllen SchletteC Cameron YinCarlos E Bueso-RamosPei LinShaoying Li

Published in: European journal of haematology (2020)

MYC-R and MYC/BCL2 DE are independent prognostic factors for DLBCL patients treated with R-CHOP. In this cohort, COO classification failed to stratify patient outcome.

Keyphrases

diffuse large b cell lymphoma
prognostic factors
epstein barr virus
transcription factor
machine learning
single cell
case report
stem cells
mesenchymal stem cells
binding protein